Table 7.
Culture source and clinical outcome among CnsECC.
| Variables | CnsECC n = 150 |
Non-CP-EnsCC n = 86 |
CP-EnsCC n = 64 |
OR (95% CI) |
p |
|---|---|---|---|---|---|
| Culture source | 0.10 | ||||
| Blood | 15 (10.0%) | 9 | 6 | 0.89 (0.30–2.63) | 0.83 |
| Sputum | 49 (32.7%) | 23 | 26 | 1.03 (0.52–2.04) | 0.93 |
| Urine | 51 (34.0%) | 29 | 22 | 1.87 (0.94–3.74) | 0.07 |
| Abscess | 21 (14.0%) | 15 | 6 | ||
| Body fluid | 7 (4.6%) | 6 | 1 | ||
| Catheter | 2 (1.3%) | 2 | 0 | ||
| BAL | 3 (2.0%) | 0 | 3 | ||
| Swab | 2 (1.3%) | 2 | 0 | ||
| Outcomes | |||||
| Length of hospitalization, (median days, IQR) | 37.5 (20–64) | 29.5 (17–57) | 45.5 (28–64) | 0.48 | |
| In-hospital mortality | 42 (28) | 17 | 25 | 2.60 (1.25–5.40) | 0.01 * |
| 30-day mortality | 33 (22) | 12 | 21 | 3.01 (1.34–6.72) | 0.007 * |
| 100-day mortality | 39 (26) | 15 | 24 | 2.84 (1.34–6.03) | 0.007 * |
Abbreviations: CnsECC, carbapenem-nonsusceptible Enterobacter cloacae complex; CP, carbapenemase-producing; IQR, interquartile range. * Statistical significance, p < 0.05.